Olivia Chaffin, center, walks in the woods with her parents, Doug, left, and Kim Chaffin, as Olivia works on a Girl Scout photography merit badge in Jonesborough, Tenn., on Sunday,
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Agios Presents Final Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in .
Agios Pharmaceuticals, Inc.January 17, 2021 GMT
CAMBRIDGE, Mass., Jan. 17, 2021 (GLOBE NEWSWIRE) Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and genetically defined diseases, today reported a full analysis of the final data, including mature overall survival (OS) results, from its global Phase 3 ClarIDHy trial of TIBSOVO® (ivosidenib tablets) in patients with previously treated isocitrate dehydrogenase 1 (IDH1) mutated cholangiocarcinoma. Data from the study were featured in an oral presentation at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO-GI), which is being held virtually January 15-17, 2021.
Press release content from Wired Release. The AP news staff was not involved in its creation.
Blood Flow Detector Market Future Business Strategy, Manufacturers Analysis and Forecast by 2031
January 15, 2021 GMT
Pune, Maharashtra, India, January 15 2021 (Wiredrelease) Prudour Pvt. Ltd :The research study on global Blood Flow Detector market presents an extensive analysis of current Blood Flow Detector trends, market size, drivers, Blood Flow Detector opportunities, challenges, and problems as well as key Blood Flow Detector market segments. Further, in the Blood Flow Detector market report,various definitions and classification of the Blood Flow Detector industry, applications and chain structure are discussed. In continuation with this data Blood Flow Detector report also covers the marketing strategies followed by Blood Flow Detector players, distributors analysis, Blood Flow Detector marketing channels, potential buyers and Blood Flow Detector development history.